We are live on ! Find out more
ARRY

Array Biopharma Inc
ARRY

Delisted

ARRY was delisted on the 29th of July, 2019.

Back to rankings

151 hedge funds and large institutions have $578M invested in Array Biopharma Inc in 2015 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 48 increasing their positions, 45 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

7% more repeat investments, than reductions

Existing positions increased: 48 | Existing positions reduced: 45

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

4% less funds holding

Funds holding: 157 → 151 (-6)

11% less capital invested

Capital invested by funds: $653M → $578M (-$75M)

18% less first-time investments, than exits

New positions opened: 23 | Existing positions closed: 28

44% less call options, than puts

Call options by funds: $6.85M | Put options by funds: $12.2M

Holders
151
Holders Change
-6
Holders Change %
-3.82%
% of All Funds
3.96%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
23
Increased
48
Reduced
45
Closed
28
Calls
$6.85M
Puts
$12.2M
Net Calls
-$5.33M
Net Calls Change
-$7.65M

Top Buyers

1
Millennium Management
Millennium Management
New York
+$11.1M
2
Renaissance Technologies
Renaissance Technologies
New York
+$10.4M
3
VAM
Visium Asset Management
New York
+$9.08M
4
OAM
Oxford Asset Management
United Kingdom
+$4.86M
5
TA
Teachers Advisors
New York
+$4.77M

Top Sellers

1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$23.5M
2
TCM
TimesSquare Capital Management
New York
-$16.6M
3
BI
BVF Inc
California
-$13.7M
4
Invesco
Invesco
Georgia
-$10.5M
5
State Street
State Street
Massachusetts
-$7.54M
Name Holding Trade Value Shares
Change 		Change in
Stake
CCMH
51
Cornerstone Capital Management Holdings
New York
$965K +$1.03M +226,277 +8,700%
Morgan Stanley
52
Morgan Stanley
New York
$955K +$188K +41,111 +22%
SFM
53
Sphera Funds Management
Israel
$907K -$616K -135,000 -39%
AllianceBernstein
54
AllianceBernstein
Tennessee
$905K – – –
BIM
55
Bogle Investment Management
Massachusetts
$893K +$966K +211,714 New
AL
56
Airain Ltd
Guernsey
$885K +$957K +209,676 New
Two Sigma Investments
57
Two Sigma Investments
New York
$868K +$385K +84,297 +69%
HI
58
HBK Investments
Texas
$843K +$786K +172,200 +624%
NI
59
Numeric Investors
Massachusetts
$821K +$732K +160,500 +471%
Swiss National Bank
60
Swiss National Bank
Switzerland
$807K – – –
BA
61
BlackRock Advisors
Delaware
$791K -$150K -32,858 -15%
BFIC
62
Bedell Frazier Investment Counselling
California
$755K +$55K +12,050 +7%
CAM
63
ClariVest Asset Management
California
$753K +$816K +178,748 New
CGT
64
Capital Guardian Trust
California
$739K – – –
HCM
65
Hollencrest Capital Management
California
$717K – – –
RhumbLine Advisers
66
RhumbLine Advisers
Massachusetts
$664K +$69.5K +15,235 +11%
Fisher Asset Management
67
Fisher Asset Management
Washington
$573K – – –
SAMC
68
Shinko Asset Management Company
Japan
$573K – – –
ProShare Advisors
69
ProShare Advisors
Maryland
$571K +$60.9K +13,337 +11%
New York State Common Retirement Fund
70
New York State Common Retirement Fund
New York
$563K – – –
CS
71
Credit Suisse
Switzerland
$554K -$3.91K -857 -0.6%
Creative Planning
72
Creative Planning
Kansas
$499K -$27.8K -6,101 -5%
VRS
73
Virginia Retirement Systems
Virginia
$466K +$504K +110,500 New
VKH
74
Virtu KCG Holdings
New York
$465K +$418K +91,494 +487%
Tudor Investment Corp
75
Tudor Investment Corp
Connecticut
$453K +$437K +95,847 +833%
1 2
3
4 5

ARRY Hedge Fund Activity: Q4 2015 in Review

151 of the 3,811 institutional investors tracked by Wall St. Rank reported a position in Array Biopharma Inc (ARRY) for Q4 2015, worth a combined $578M — down 11% from $653M a quarter earlier.

Sellers outnumbered buyers: 28 funds closed out of ARRY and 23 opened new positions — a net loss of 5 holders — while 45 trimmed existing stakes and 48 added.

The largest buyer was Millennium Management, adding an estimated $11.1M. The largest seller was T. Rowe Price Associates, exiting entirely with an estimated $23.5M sold.

  • 151 institutional investors held Array Biopharma Inc (ARRY) as of Q4 2015, down from 157 in Q3 2015.
  • Funds reported $578M of Array Biopharma Inc stock for Q4 2015, down 11% quarter-over-quarter.
  • 23 funds opened new Array Biopharma Inc positions in Q4 2015 and 28 closed out, a net change of -5 holders.
  • The largest Array Biopharma Inc buyer in Q4 2015 was Millennium Management, an estimated $11.1M added.
  • The largest Array Biopharma Inc seller in Q4 2015 was T. Rowe Price Associates, an estimated $23.5M sold.

Based on aggregated 13F filings for Q4 2015.